Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005
Published online before print October 6, 2005, doi: 10.1161/01.RES.0000189260.46084.e5
A more recent version of this article appeared on November 11, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
97/10/1001    most recent
01.RES.0000189260.46084.e5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toraty-Jain, H.
Right arrow Articles by Sasson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toraty-Jain, H.
Right arrow Articles by Sasson, S.
Related Collections
Right arrow Energy metabolism
Right arrow Type 1 diabetes
Right arrow Type 2 diabetes
Right arrow Other Vascular biology
Right arrow Other Research
Right arrowRelated Article

Submitted on August 15, 2005
Revised on September 8, 2005
Accepted on September 22, 2005

Calreticulin Destabilizes Glucose Transporter-1 mRNA in Vascular Endothelial and Smooth Muscle Cells Under High-Glucose Conditions

Hana Toraty-Jain ; Tally Naveh-Many ; Yael Riahi ; Nurit Kaiser ; Jürgen Eckel ; and Shlomo Sasson *

From the Department of Pharmacology (H.T.-J., Y.R., S.S.), School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel; The Nephrology (T.N.-M.) and Endocrinology & Metabolism (N.K.) Services, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; and Department of Clinical Biochemistry and Pathobiochemistry (J.E.), German Diabetes Center, Düsseldorf, Germany.

* To whom correspondence should be addressed. E-mail: sassolo{at}cc.huji.ac.il.

Substrate autoregulation of glucose transporter-1 (GLUT-1) mRNA and protein expression provides vascular endothelial and smooth muscle cells a sensitive mechanism to adapt their rate of glucose transport in response to changing glycemic conditions. Hyperglycemia-induced downregulation of glucose transport is particularly important in protecting these cells against an excessive influx of glucose and consequently increased intracellular protein glycation and generation of free radicals; both are detrimental in the development of vascular disease in diabetes. We aimed to investigate the molecular mechanism of high glucose-induced downregulation of GLUT-1 mRNA expression in primary bovine aortic vascular endothelial (VEC) and vascular smooth muscle (VSMC) cell cultures. Using RNA mobility shift, UV cross-linking, and in vitro degradation assays, followed by mass-spectrometric analysis, we identified calreticulin as a specific destabilizing trans-acting factor that binds to a 10-nucleotide cis-acting element (CAE2181 to 2190) in the 3'-untranslated region of GLUT-1 mRNA. Pure calreticulin accelerated the rate of GLUT-1 mRNA-probe degradation in vitro, whereas overexpression of calreticulin in vascular cells decreased significantly the total cell content of GLUT-1 mRNA and protein. The expression of calreticulin was augmented in vascular cells exposed to high glucose in comparison with low-glucose conditions. Similarly, increased expression of calreticulin was observed in aortae of diabetic Psammomys obesus in comparison with normoglycemic controls. These data suggest that CAE2181 to 2190-calreticulin complex, which is formed in VSMC and VEC exposed to hyperglycemic conditions, renders GLUT-1 mRNA susceptible to degradation. This interaction underlies the process of downregulation of glucose transport in vascular cells under high-glucose conditions.


Key words: calreticulin • glucose transporter-1 • hyperglycemia • mRNA turnover • vascular smooth muscle cells • vascular endothelial cells


Related Article:

New Function of Calreticulin: Calreticulin-Dependent mRNA Destabilization
Mitsuhiro Yokoyama and Ken-ichi Hirata
Circ. Res. 2005 97: 961-963. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. Gao, H. Fei, N. C. Connors, J. Zhang, and I. B. Levitan
Drosophila Ortholog of Succinyl-CoA Synthetase {beta} Subunit: A Novel Modulator of Drosophila KCNQ Channels
J Neurophysiol, May 1, 2008; 99(5): 2736 - 2740.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Yokoyama and K.-i. Hirata
New Function of Calreticulin: Calreticulin-Dependent mRNA Destabilization
Circ. Res., November 11, 2005; 97(10): 961 - 963.
[Full Text] [PDF]